Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Boyd

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Contraception|June 28, 2019
Post-use ring weight and residual drug content as potential objective measures of user adherence to a contraceptive progesterone vaginal ringDiarmaid J Murphy, Clare F McCoy, Marlena Plagianos, et al.
International Journal of Pharmaceutics|July 29, 2019
Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomersYahya H Dallal Bashi, Clare F McCoy, Diarmaid J Murphy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2015
Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, AustraliaPaul J Clark, Katherine A Stuart, Barbara A Leggett, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 17, 2016
Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring deviceDiarmaid J Murphy, Peter Boyd, Clare F McCoy, et al.
International Journal of Pharmaceutics|April 19, 2019
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTESJohn W McBride, R Karl Malcolm, Nicola Dias, et al.
The Journal of Antimicrobial Chemotherapy|January 2, 2014
Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral applicationR Karl Malcolm, Deborah Lowry, Peter Boyd, et al.
Plos One|September 4, 2020
Chronic hepatitis B in remote, tropical Australia; successes and challengesJosh Hanson, Melissa Fox, Adam Anderson, et al.
Alzheimer Disease and Associated Disorders|July 17, 2025
An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy SubjectsSumit Rawal, Kristin R Wildsmith, Jagadeesh Aluri, et al.
Plos One|May 13, 2015
A temperature-monitoring vaginal ring for measuring adherencePeter Boyd, Delphine Desjardins, Sandeep Kumar, et al.
International Journal of Pharmaceutics: X|May 24, 2021
Use of simulated vaginal and menstrual fluids to model <i>in vivo</i> discolouration of silicone elastomer vaginal ringsClare F McCoy, Patrick Spence, Yahya H Dallal Bashi, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Contraception|June 28, 2019
Post-use ring weight and residual drug content as potential objective measures of user adherence to a contraceptive progesterone vaginal ringDiarmaid J Murphy, Clare F McCoy, Marlena Plagianos, et al.
International Journal of Pharmaceutics|July 29, 2019
Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomersYahya H Dallal Bashi, Clare F McCoy, Diarmaid J Murphy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2015
Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, AustraliaPaul J Clark, Katherine A Stuart, Barbara A Leggett, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 17, 2016
Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring deviceDiarmaid J Murphy, Peter Boyd, Clare F McCoy, et al.
International Journal of Pharmaceutics|April 19, 2019
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTESJohn W McBride, R Karl Malcolm, Nicola Dias, et al.
The Journal of Antimicrobial Chemotherapy|January 2, 2014
Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral applicationR Karl Malcolm, Deborah Lowry, Peter Boyd, et al.
Plos One|September 4, 2020
Chronic hepatitis B in remote, tropical Australia; successes and challengesJosh Hanson, Melissa Fox, Adam Anderson, et al.
Alzheimer Disease and Associated Disorders|July 17, 2025
An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy SubjectsSumit Rawal, Kristin R Wildsmith, Jagadeesh Aluri, et al.
Plos One|May 13, 2015
A temperature-monitoring vaginal ring for measuring adherencePeter Boyd, Delphine Desjardins, Sandeep Kumar, et al.
International Journal of Pharmaceutics: X|May 24, 2021
Use of simulated vaginal and menstrual fluids to model <i>in vivo</i> discolouration of silicone elastomer vaginal ringsClare F McCoy, Patrick Spence, Yahya H Dallal Bashi, et al.
Pageof 7